Clarius Unveils Updated Ultrasound Software to Enhance Workflows
The latest ultrasound software update from Clarius includes new artificial intelligence (AI) capabilities, coding assistance and a variety of advances tailored to different fields of medicine.
Emphasizing enhancements in workflow efficiency, high-definition imaging, and artificial intelligence (AI) guidance, Clarius has introduced updated software for its handheld ultrasound systems.
One of the features available through the Clarius App 12.0 is a 12-field lung ultrasound scoring tool that facilitates evaluation of patients with respiratory conditions and accurate prognosis of outcomes for those with acute respiratory failure, according to Clarius.
Updated software for Clarius handheld ultrasound devices includes a lung ultrasound scoring tool and coding assistance for ultrasound applications in musculoskeletal imaging, urology and women’s health, according to the company. (Image courtesy of Clarius.)
Clarius noted that other benefits of the updated software include T-Mode real-time AI guidance for assessing grey scale ultrasound images for patients with rotator cuff injuries; a new protocol to facilitate change settings to ensure optimized facial scans for aesthetic procedures; and coding assistance for ultrasound applications in musculoskeletal imaging, urology and women’s health.
“This latest software release, which includes so many unique features, clearly demonstrates the limitless ability of our R&D team to deliver ground-breaking innovations across multiple clinical segments in ultrasound,” noted Ohad Arazi, the CEO of Clarius.
The company said the Clarius App 12.0 was recently launched in Apple and Google Play platforms.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
